Literature DB >> 21601625

Determination of the scale of segregation of low dose tablets using hyperspectral imaging.

David R Ely1, M Teresa Carvajal.   

Abstract

In this work, near infrared (NIR) hyperspectral imaging was used to quantify the spatial distribution of drug in tablets containing tolmetin sodium dihydrate. Hyperspectral data cubes were generated by imaging the same spatial region of a sample while illuminated by a laser at a different wavelength for each image. Images were generated for wavelengths ranging from 1100 to 2200 nm. Ten tablets with concentrations ranging from 0.0 to 10.0% w/w tolmetin were imaged, and the scales of segregation were calculated for the tablets. Lactose anhydrous was used as the diluent, and all mixtures contained 0.5% magnesium stearate as a lubricant. This research has shown hyperspectral imaging to be viable tool for quantifying segregation of low dose drugs in tablets.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601625     DOI: 10.1016/j.ijpharm.2011.05.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Spherical Agglomerates of Lactose Reduce Segregation in Powder Blends and Improve Uniformity of Tablet Content at High Drug Loads.

Authors:  Dejan Lamešić; Blaž Grilc; Robert Roškar; Selina Kolokytha; Jürgen Hofmann; Andreas Malekos; Rolf Kaufmann; Odon Planinšek
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

2.  Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.

Authors:  Chih-Jen Wen; Li-Wen Zhang; Saleh A Al-Suwayeh; Tzu-Chen Yen; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2012-03-26

3.  Assessment of active pharmaceutical ingredient particle size in tablets by Raman chemical imaging validated using polystyrene microsphere size standards.

Authors:  Atsushi Kuriyama; Yukihiro Ozaki
Journal:  AAPS PharmSciTech       Date:  2014-01-11       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.